Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Vaccine

Meningitis outbreak: calls grow for wider vaccine rollout after Oxfordshire teen dies

The heartbreaking loss of a student in Oxfordshire due to meningitis has sparked renewed advocacy for comprehensive vaccination programs for teens across the UK. With one case of Meningitis B confirmed and further inquiries underway, health experts are rallying for updated immunizations.

The Times of India

Trump's Top Hantavirus Official Is a Penile Implant Specialist Who Hosted a Conspiracy Theory Podcast

Dr. Brian Christine, a former urologist, now leads US public health efforts despite a controversial past involving conspiracy theories and scepticism towards Covid vaccines.

International Business Times UK

Charity chief calls for wider rollout of meningitis vaccine

A college student died in Oxfordshire after contracting the disease.

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

BioNTech Maps Oncology Push, $1B Buyback and Manufacturing Cuts at AGM

BioNTech (NASDAQ:BNTX) used its virtual annual general meeting to outline a transition year marked by leadership changes, continued investment in oncology, a planned share repurchase program and a restructuring of its manufacturing network. Chairman of the Supervisory Board Helmut Jeggle said the 2

MarketBeat

Hantavirus outbreak: Scientists ran out of funds while developing a vaccine, report says

A Hantavirus outbreak linked to the MV Hondius cruise ship has tragically claimed three lives this year, with 11 cases reported. While infections are rare, this outbreak highlights the urgent need for a vaccine, with research stalled by funding issues. International efforts are underway to manage the current situation, focusing…

The Times of India

Hantavirus scientists were close to vaccine but ran out of money

Scientists in Chile developed antibodies that successfully neutralised the deadly Andes hantavirus in lab and animal studies, raising hopes for a treatment against the rare virus that can spread between people. But the project stalled before human trials due to lack of funding and the Covid-19 pandemic.

The Economic Times

Valneva Q1 Earnings Call Highlights

Valneva (NASDAQ:VALN) reported lower first-quarter revenue and a wider loss for 2026, while management said the company is focused on conserving cash as it awaits the next regulatory steps for its Lyme disease vaccine candidate being developed with Pfizer. Chief Executive Officer Thomas Lingelbach

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Staged claims and Israeli hoaxes: Debunking viral conspiracy theories about hantavirus

Misinformation about hantavirus has run rampant on social media, with online users reviving viral COVID-19 theories to spread fake news about the outbreak.

Euronews

Is there a hantavirus vaccine? Scientists race to develop one for new strain

A deadly hantavirus outbreak on a cruise ship has raised fears over emerging viruses with no cure or vaccine. The UK government had already commissioned researchers to develop what could become the world’s first hantavirus vaccine

Euronews

Urgent care clinics, medicines and vaccines: what the budget means for Australians’ health

Health was at the heart of last year’s budget. Last night, tax and housing took centre stage, and there were few surprises in health.

The Conversation

Capricor Therapeutics Q1 Earnings Call Highlights

Capricor Therapeutics (NASDAQ:CAPR) said its Duchenne muscular dystrophy therapy candidate deramiocel remains under active FDA review, while the company is preparing to commercialize the product itself amid a legal dispute with distribution partner NS Pharma and parent company Nippon Shinyaku. On t

MarketBeat

The White House told RFK Jr to tone down his statements questioning vaccines. That hasn’t stopped him behind the scenes

The reported review concerns Kennedy’s long-held skepticism of mainstream vaccine science

The Independent UK

Is There A Cure For Hantavirus Infection? 'Breathed In' Virus Kills 38% Of Patients, Scientists Race For Vaccine

A deadly cruise ship outbreak of the Andes strain has revived global interest in a long‑delayed hantavirus cure, as scientists warn that early hospital care can make the difference between survival and a 38% fatality risk.

International Business Times UK

Free meningococcal jabs for some but 'lottery' persists

A fourth Australian jurisdiction will provide free jabs to some teens for a rare but life-threatening disease as the push for national coverage marches on.

AAP

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

The Guardian view on the WHO pandemic treaty: the west’s fantasy negotiations have put the world at risk

Editorial: After five years of deliberation the global south has forced the question that defined the Covid crisis: who will get the vaccines?

The Guardian - US

‘The FDA is a complete mess’: Trump makes fate of agency chief unclear as public trust plummets

Food and Drug Administration commissioner’s decisions have hurt staff morale and put his job in crosshairs

Reason

Trump's Health Bureaucrats Are Undermining Confidence in Vaccines

From spiked CDC reports to blocked FDA studies, officials sidelined evidence showing vaccines are safe and effective.

The Independent UK

FDA's new playbook: Lots of media announcements but not much rulemaking

Health Secretary Robert F. Kennedy Jr. and other health officials have repeatedly announced major changes before any new rules have been drafted

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

‘People should be talking about it’: moves to curtail vaccine information obscures important science, doctors say

Quashed studies, halted publications and canceled research threaten damage to public health, critics say

International Business Times

HHS Studies That Found Covid, Shingles Vaccines Safe And Effective Pulled From Scientific Journals

The Food and Drug Administration (FDA) has withdrawn studies that suggested COVID-19 and shingles vaccines were safe and effective.

The Independent UK

Trump’s third surgeon general pick is deleting old posts critical of president’s agenda and fitness

Dr Nicole Saphier, a radiologist, author and Fox News contributor, scrubs X account of posts questioning administration’s handling of issues related to autism and vaccines

Latin Times

Experts Criticize F.D.A. Move to Withhold Studies on Vaccine Safety: 'A Pretty Active Act of Sabotage'

Blocked publications on COVID and shingles vaccines come amid broader changes to federal policy under Health Secretary Robert F. Kennedy Jr., a longtime vaccine critic

Budget and the Bees

Unexpected Ally: Shingles Vaccine Cuts Heart Attacks Nearly in Half

A growing body of research is reshaping how we think about vaccines, and not just for preventing infections. The shingles vaccine, long recommended for older adults to prevent painful rashes, is now gaining attention for an unexpected benefit: reducing the risk of heart attacks. Recent studies suggest that people who…

The Independent UK

On The Ground | Inside the ‘miracle’ drug rollout that could end Aids

A groundbreaking new drug to prevent HIV infection – the closest the world has to a vaccine – is being rolled out in some of the worst-hit countries in the world. Chief international correspondent Bel Trew reports from Eswatini, southern Africa, where there is hope that the pandemic could be…

The Guardian - US

FDA blocked studies finding Covid and shingles vaccines safe, HHS official says

Serious side-effects from vaccines were rare, scientists found in studies funded by US taxpayer money

1 … 7 8 9 10

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Wall Street Journal

Health and Human Services

283 stories

Mainz

269 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.